Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data

BACKGROUND: No randomized controlled trials have been completed to see whether statin can decrease hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients. We used large-scale, population-based, observational data to emulate a target trial with two groups, statin user and statin no...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinn, Dong Hyun, Kang, Danbee, Park, Yewan, Kim, Hyunsoo, Hong, Yun Soo, Cho, Juhee, Gwak, Geum-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601275/
https://www.ncbi.nlm.nih.gov/pubmed/37880589
http://dx.doi.org/10.1186/s12876-023-02996-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601275/
https://www.ncbi.nlm.nih.gov/pubmed/37880589
http://dx.doi.org/10.1186/s12876-023-02996-w

Ejemplares similares